[HTML][HTML] Exosome nanovesicles: a potential carrier for therapeutic delivery

VP Chavda, A Pandya, L Kumar, N Raval, LK Vora… - Nano Today, 2023 - Elsevier
Exosomes are small nanosized biovesicles that form when multivesicular bodies and the
plasma membrane fuse and are released into the surrounding body fluids. They are best …

Insights into exosome transport through the blood–brain barrier and the potential therapeutical applications in brain diseases

M Abdelsalam, M Ahmed, Z Osaid, R Hamoudi… - Pharmaceuticals, 2023 - mdpi.com
Drug delivery to the central nervous system (CNS) is limited due to the presence of the blood–
brain barrier (BBB), a selective physiological barrier located at the brain microvessels that …

[HTML][HTML] Neuroprotective effects of coenzyme Q10-loaded exosomes obtained from adipose-derived stem cells in a rat model of Alzheimer's disease

M Sheykhhasan, R Amini, SS Asl, M Saidijam… - Biomedicine & …, 2022 - Elsevier
Alzheimer's disease (AD) is a degenerative disease that causes memory and learning
impairments as well as dementia. Coenzyme Q10 (CoQ10) is an anti-inflammatory and anti …

Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine

Y Matsuzaka, R Yashiro - International Journal of Molecular Sciences, 2022 - mdpi.com
Extracellular vesicles (EVs) are lipid bilayer membrane particles that play critical roles in
intracellular communication through EV-encapsulated informative content, including …

Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review

Z Chen, M Xiong, J Tian, D Song, S Duan… - Journal of …, 2024 - Springer
Exosomes are nanoscale extracellular vesicles secreted by cells and enclosed by a lipid
bilayer membrane containing various biologically active cargoes such as proteins, lipids …

Blood extracellular vesicles carrying synaptic function‐and brain‐related proteins as potential biomarkers for Alzheimer's disease

C Tian, T Stewart, Z Hong, Z Guo, P Aro… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Objective and accessible markers for Alzheimer's disease (AD) and other
dementias are critically needed. Methods We identified NMDAR2A, a protein related to …

Nanomaterials-based exosomes for the diagnostics and drug deliveries of central nervous system diseases

I Haizan, DH Park, MY Choi, H Lee, JH Choi - BioChip Journal, 2023 - Springer
With the increasing number of patients suffering from central nervous system (CNS)
diseases, there is a pressing demand to acquire dependable diagnostic tools in the early …

[HTML][HTML] Astrocyte-derived extracellular vesicles for ischemic stroke: therapeutic potential and prospective

X Wang, A Li, H Fan, Y Li, N Yang, Y Tang - Aging and Disease, 2024 - ncbi.nlm.nih.gov
Stroke is a leading cause of death and disability in the world. Astrocytes are special glial
cells within the central nervous system and play important roles in mediating …

Nanotechnology-inspired extracellular vesicles theranostics for diagnosis and therapy of central nervous system diseases

T Tian, S Qiao, BA Tannous - ACS Applied Materials & Interfaces, 2022 - ACS Publications
Shuttling various bioactive substances across the blood–brain barrier (BBB) bidirectionally,
extracellular vesicles (EVs) have been opening new frontiers for the diagnosis and therapy …

Unraveling the intricate roles of exosomes in cardiovascular diseases: A comprehensive review of physiological significance and pathological implications

S Zhang, Y Yang, X Lv, W Liu, S Zhu, Y Wang… - International Journal of …, 2023 - mdpi.com
Exosomes, as potent intercellular communication tools, have garnered significant attention
due to their unique cargo-carrying capabilities, which enable them to influence diverse …